The Power of Networking in Medtech, Challenges in Developing the Renal Denervation Market, and the Value of Cross-Functional Experience: Interview with Shaun Bagai, CEO of RenovoRx

The Power of Networking in Medtech, Challenges in Developing the Renal Denervation Market, and the Value of Cross-Functional Experience: Interview with Shaun Bagai, CEO of RenovoRx

vor 9 Jahren
43 Minuten
0
0 0 0
Podcast
Podcaster
Learn from proven medtech and healthtech experts. That's our primary goal with Medsider. Through uncut interviews with the world's brightest thought leaders, you'll pick up on helpful insights, lessons learned, best practices, and much more.

Beschreibung

vor 9 Jahren

Shaun Bagai is the CEO of RenovoRx.  He has over 16 years of
medtech experience across multiple functional areas like clinical
research, sales, marketing, and market development. He was
instrumental in developing the European market for renal
denervation, which led to the acquisition of the first renal
denervation company, Ardian, by Medtronic in 2011. Most...[read
more]

Related Stories


Why Intersect ENT is an Example of Hope for the Medtech
Industry

Are Medical Device Models the Key to Building a Lean Medtech
Startup?

Substantial and Sustainable – 2 Words That Medtech Companies
Should Get Used To 

15
15
Close